327 related articles for article (PubMed ID: 11472410)
1. Antilactoferrin antibodies in autoimmune liver disease.
Muratori L; Muratori P; Zauli D; Grassi A; Pappas G; Rodrigo L; Cassani F; Lenzi M; Bianchi FB
Clin Exp Immunol; 2001 Jun; 124(3):470-3. PubMed ID: 11472410
[TBL] [Abstract][Full Text] [Related]
2. Anti-neutrophil cytoplasmic antibodies in patients with chronic liver diseases: prevalence, antigen specificity and predictive value for diagnosis of autoimmune liver disease. Swedish Internal Medicine Liver Club (SILK).
Lindgren S; Nilsson S; Nässberger L; Verbaan H; Wieslander J
J Gastroenterol Hepatol; 2000 Apr; 15(4):437-42. PubMed ID: 10824890
[TBL] [Abstract][Full Text] [Related]
3. Autoimmune liver disease-related autoantibodies in patients with biliary atresia.
Pang SY; Dai YM; Zhang RZ; Chen YH; Peng XF; Fu J; Chen ZR; Liu YF; Yang LY; Wen Z; Yu JK; Liu HY
World J Gastroenterol; 2018 Jan; 24(3):387-396. PubMed ID: 29391761
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases.
Mulder AH; Horst G; Haagsma EB; Limburg PC; Kleibeuker JH; Kallenberg CG
Hepatology; 1993 Mar; 17(3):411-7. PubMed ID: 8444414
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
6. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
7. Antilactoferrin antibodies in autoimmune liver diseases.
Ohana M; Okazaki K; Hajiro K; Uchida K
Am J Gastroenterol; 1998 Aug; 93(8):1334-9. PubMed ID: 9707061
[TBL] [Abstract][Full Text] [Related]
8. Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases.
Claise C; Johanet C; Bouhnik Y; Kapel N; Homberg JC; Poupon R
Liver; 1996 Feb; 16(1):28-34. PubMed ID: 8868075
[TBL] [Abstract][Full Text] [Related]
9. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.
Orth T; Gerken G; Meyer Zum Büschenfelde KH; Mayet WJ
Z Gastroenterol; 1997 Feb; 35(2):113-21. PubMed ID: 9066101
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies to beta tubulin in autoimmune liver diseases-Relation to pANCA and clinical relevance.
Preuß B; Frank A; Terjung B; Spengler U; Berg C; Klein R
Clin Exp Immunol; 2024 Apr; 216(2):146-158. PubMed ID: 37823420
[TBL] [Abstract][Full Text] [Related]
11. Rheumatic Disease Autoantibodies in Autoimmune Liver Diseases.
Utiyama SR; Zenatti KB; Nóbrega HA; Soares JZ; Skare TL; Matsubara C; Muzzilo DA; Nisihara RM
Immunol Invest; 2016 Aug; 45(6):566-73. PubMed ID: 27409579
[TBL] [Abstract][Full Text] [Related]
12. Serum autoantibodies for the diagnosis and management of autoimmune liver diseases.
Achenza MI; Meda F; Brunetta E; Selmi C
Expert Rev Gastroenterol Hepatol; 2012 Dec; 6(6):717-29. PubMed ID: 23237257
[TBL] [Abstract][Full Text] [Related]
13. Autoimmune liver serology: current diagnostic and clinical challenges.
Bogdanos DP; Invernizzi P; Mackay IR; Vergani D
World J Gastroenterol; 2008 Jun; 14(21):3374-87. PubMed ID: 18528935
[TBL] [Abstract][Full Text] [Related]
14. Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass.
Bansi D; Chapman R; Fleming K
J Hepatol; 1996 May; 24(5):581-6. PubMed ID: 8773914
[TBL] [Abstract][Full Text] [Related]
15. Intrahepatic IgG/IgM plasma cells ratio helps in classifying autoimmune liver diseases.
Cabibi D; Tarantino G; Barbaria F; Campione M; Craxì A; Di Marco V
Dig Liver Dis; 2010 Aug; 42(8):585-92. PubMed ID: 20060371
[TBL] [Abstract][Full Text] [Related]
16. IgA anti-b2GPI antibodies in patients with autoimmune liver diseases.
Gabeta S; Norman GL; Gatselis N; Liaskos C; Papamichalis PA; Garagounis A; Zachou K; Rigopoulou EI; Dalekos GN
J Clin Immunol; 2008 Sep; 28(5):501-11. PubMed ID: 18551357
[TBL] [Abstract][Full Text] [Related]
17. The clinical usage and definition of autoantibodies in immune-mediated liver disease: A comprehensive overview.
Terziroli Beretta-Piccoli B; Mieli-Vergani G; Vergani D
J Autoimmun; 2018 Dec; 95():144-158. PubMed ID: 30366656
[TBL] [Abstract][Full Text] [Related]
18. Relevance of the inner mitochondrial membrane enzyme F1F0-ATPase as an autoantigen in autoimmune liver disorders.
Preuss B; Berg C; Dengjel J; Stevanovic S; Klein R
Liver Int; 2012 Feb; 32(2):249-57. PubMed ID: 22098431
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases.
Roozendaal C; de Jong MA; van den Berg AP; van Wijk RT; Limburg PC; Kallenberg CG
J Hepatol; 2000 May; 32(5):734-41. PubMed ID: 10845659
[TBL] [Abstract][Full Text] [Related]
20. Autoantibodies in autoimmune liver diseases.
Sener AG
APMIS; 2015 Nov; 123(11):915-9. PubMed ID: 26359647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
